Doç. Dr. Yaşa Gül Mutlu

Experience

• 2019-2020Muş Devlet Hastanesiİç Hastalıkları Uzmanı
• 2014-2015Çanakkale Devlet HastanesiPratisyen Hekim

Education

• 2020-2024İstanbul Medipol Üniversitesi, Hematoloji Yan Dal Uzmanlık Eğitimiflorence.com.tr
• 2017-2019Dokuz Eylül Üniversitesi Tıp Fakültesi, İç Hastalıkları Uzmanlık Eğitimiflorence.com.tr
• 2015-2017Çukurova Üniversitesi Tıp Fakültesi, İç Hastalıkları Uzmanlık Eğitimiflorence.com.tr
• 2008-2014Mustafa Kemal Üniversitesi Tıp Fakültesi, Tıp Eğitimiflorence.com.tr

• SpecialtyHaematologyflorence.com.trFrom source
• Institutionİstanbul Florence Nightingale Hastanesiflorence.com.trFrom source
• Publications21 publicationsflorence.com.tr profile pageFrom source
• Last synchronised7 November 2026 07:30https://www.florence.com.tr/doktorlar/uzm-dr-yasa-gul-mutluflorence.com.tr

1. Balik Aydin B, Mutlu YG, Sevindik OG. Persistent Polyclonal B-Cell Lymphocytosis with Binucleated Lymphocytes. Turk J Haematol. 2021;38(2):173-4.

   Source: florence.com.tr profile page

2. Civriz Bozdag S, Cengiz Seval G, Yonal Hindilerden I, Hindilerden F, Andic N, Baydar M, …. Mutlu YG ,…et al. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies. Turk J Haematol. 2022;39(1):43- 54.

   Source: florence.com.tr profile page

3. Sevindik OG, Mergen M, Mergen S, Mutlu YG, Aydin BB, Serin I. To rechallenge or not to rechallenge, that is the question? An unsuccessful attempt of hypomethylating agent plus venetoclax in an elderly FLT3-positive relapsed acute myeloid leukemia patient after a yearlong period of remission. Ann Hematol. 2022;101(11):2545-7.

   Source: florence.com.tr profile page

4. Sevindik OG, Mutlu YG, Aydin BB, Serin I. First-line Usage of Daratumumab, Lenalidomide, Dexamethasone (DRd) Combination in a Case of Castleman Disease Variant of Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome (CD-POEMS). Hemasphere. 2022;6(7):e728.

   Source: florence.com.tr profile page

5. Yigit Kaya S, Bektas S, Askin AE, Balik Aydin B, Mutlu YG, Sevindik OG. Pegaspargase, venetoclax, and nelarabine: a successful bridge to allogeneic hematopoietic stem cell transplantation in a relapsed/refractory T-cell acute lymphoblastic leukemia patient. Ann Hematol. 2023;102(6):1599-600.

   Source: florence.com.tr profile page

6. Mutlu YG, Aydin BB, Erdogan C, Kizilaslan D, Bekoz HS, Gemici A, et al. Prognostic Factors and Intensive Care Outcome in Post-Transplant Phase of Hematopoietic Stem Cell Transplantation: Intensive Care Outcome in Hematopoietic Stem Cell Transplantation. Indian J Hematol Blood Transfus. 2023;39(2):167-72.

   Source: florence.com.tr profile page

7. Mutlu YG, Balik Aydin B, Ayaz A, Seca F, Sevindik OG. Mutation profile of the patients diagnosed with myeloid neoplasia tested with next generation sequencing andclinical implications. Annals of Medical Research. 2022; 29(4), 406-411.

   Source: florence.com.tr profile page

8. Sadri S. , Yönal Hindilerden İ. , Mutlu YG. , Tiryaki T. O. , Gemici A. İ. , Bekoz H. S. , Gökmen Sevindik Ö. , Hindilerden F. , Kalayoğlu beşışık S. , Nalçacı M. , Sargın D. Comparison of different plerixafor-based strategies for adequate hematopoietic stem cell collection in poor mobilizers. Eur Res J. 2023; 1-12.

   Source: florence.com.tr profile page

9. Mutlu YG, Aydin BB, Cakir A, Canoz O, Erol C, Sevindik OG.Should core needle lymph node biopsy be a relevant alternative to surgical excisional biopsy in diagnostic work up of lymphomas? 2023, Eurasian J Med.

   Source: florence.com.tr profile page

10. Erol VB, Mutlu YG, Aydin BB, Mert A, Sevindik OG. Intravascular B cell lymphoma with generalized telangiectasias: a rare entity. 2023, J Dtsch Dermatol Ges.

    Source: florence.com.tr profile page